NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080220732

Registered date:13/05/2009

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedPain
Date of first enrollment13/05/2009
Target sample size
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : AZD1386 INN of investigational material : Therapeutic category code : 114 Antipyretics, analgesics and anti-inflammatory agents Dosage and Administration for Investigational material : Oral, during 4 weeks

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 40age old
Age maximum<= 80age old
GenderBoth
Include criteria- Patients with OA of the knee
Exclude criteria- A current diagnosis of another form of arthritis, in addition to OA - History, and/or presence of somatic disease, which may interfere with the objectives

Related Information

Contact

Public contact
Name
Address RD-clinical-information-Japan@astrazeneca.com
Telephone
E-mail
Affiliation AstraZeneca KK
Scientific contact
Name
Address
Telephone
E-mail
Affiliation